Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.40 and traded as low as $0.30. Northwest Biotherapeutics shares last traded at $0.30, with a volume of 1,496,670 shares changing hands.
Northwest Biotherapeutics Price Performance
The firm has a market capitalization of $383.78 million, a P/E ratio of -3.72 and a beta of -0.58. The business’s 50 day moving average is $0.32 and its 200-day moving average is $0.40.
Northwest Biotherapeutics (OTCMKTS:NWBO – Get Free Report) last announced its quarterly earnings data on Friday, August 9th. The biotechnology company reported ($0.02) earnings per share for the quarter. The company had revenue of $0.51 million during the quarter.
Northwest Biotherapeutics Company Profile
Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient’s own immune system to attack cancer.
Featured Stories
- Five stocks we like better than Northwest Biotherapeutics
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Misses and Beats: 3 Stocks That Are Moving Markets Right Now
- What is the Hang Seng index?
- Cisco on the Rise: AI Potential and Analyst Upgrades Drive Gains
- Why Invest in High-Yield Dividend Stocks?
- MarketBeat Week in Review – 10/14 – 10/18
Receive News & Ratings for Northwest Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northwest Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
